Galetzka, D.; Böck, J.; Wagner, L.; Dittrich, M.; Sinizyn , O.; Ludwig, M.; Rossmann, H.; Spix, C.; Radsak, M.; Scholz-Kreisel, P.; Mirsch, J.; Linke, M.; Brenner, W.; Marron, M.; Poplawski, A.; Haaf, T.; Schmidberger, H.; Prawitt, D. Hypermethylation of RAD9A Intron 2 in Childhood Cancer Patients, Leukemia and Tumor Cell Lines Suggest a Role for Oncogenic Transformation. EXCLI J. 2022, 21, 117-143.